Decoding 'Lannett 0795 Orange': More Than Just a Code

You might see 'Lannett 0795 Orange' and wonder what on earth it refers to. Is it a paint color? A product code for something obscure? As it turns out, it's a bit more nuanced, touching on the world of pharmaceuticals and regulatory processes.

When we talk about the 'Orange Book,' we're actually referring to the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations. It's a comprehensive list, updated monthly, that plays a crucial role in the approval of generic drugs. Think of it as a guide for companies looking to bring more affordable versions of existing medications to market.

The 'Orange Book' lists drugs that the FDA has designated as reference standards. These are the original, brand-name drugs (or their approved generic equivalents) that a company seeking to market a generic version must demonstrate their product is equivalent to. The goal is to ensure that generic drugs are safe, effective, and perform the same way as their brand-name counterparts.

So, what about 'Lannett 0795 Orange'? Lannett is a pharmaceutical company, and the '0795' likely refers to a specific drug product or application number within their portfolio. The 'Orange' part, as we've established, points to its listing or relevance within the FDA's Orange Book framework. It signifies that a particular Lannett product is recognized in relation to a reference listed drug (RLD) for the purpose of an Abbreviated New Drug Application (ANDA).

This process is vital for making healthcare more accessible. By allowing generic drug manufacturers to rely on the FDA's established evaluations, the pathway to market for generics is streamlined, which in turn can lead to lower drug prices for consumers. It's a complex system, but at its heart, it's about ensuring quality and accessibility in medicine.

It's fascinating how a seemingly simple string of characters can unlock a whole world of regulatory science and pharmaceutical development. It reminds us that behind every product, there's often a story of innovation, regulation, and a commitment to public health.

Leave a Reply

Your email address will not be published. Required fields are marked *